ArticleTransboundary and emerging diseases2025
Analysis of Genetic Diversity Based on Sequences of Feline Calicivirus Strains Isolated in China.
Article in Transboundary and emerging diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Localized adaptive evolution in VP1 drives antigenic divergence of feline calicivirus despite high sequence conservation.Veterinary research · 2026Article
- Evaluating Neutralizing Antibody Titers by Recombinant Feline Calicivirus with Heterologous Capsid Protein VP1.Animals : an open access journal from MDPI · 2026Article
- Construction of Reverse Genetics System for Feline Calicivirus FCV-BJ616 and Proteomic Analysis.MicrobiologyOpen · 2026Article
- A Virulent Systemic Feline Calicivirus Strain Isolated in China Could Produce Broadly Neutralizing Antibodies Against Multiple Strains.Transboundary and emerging diseases · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In recent years, feline calicivirus (FCV) has caused increasingly severe harm in China, posing a significant threat to feline health. However, our understanding of the complex epidemiology and genetic diversity of FCV in China remains limited. In this study, we integrated various bioinformatics methods and used isolates from China as the primary research subjects. The approach ranged from basic prevalence statistics to genome sequence analysis, systematic exploration of spatiotemporal evolution, recombination studies, comparisons of specific sites, structural biology predictions, protein adaptation analysis, and molecular dynamics simulations. This comprehensive approach aimed to obtain a thorough understanding of the characteristics of FCV in China. An in-depth analysis of the results indicates that FCV exhibits a nationwide epidemic trend in China mainly consisting of two genotypes: GI and GII. The prevalence rate of genotype GI exceeds 70%, making it the predominant epidemic genotype. Spatiotemporal evolution predicts that the ancestor of genotype GI emerged in 1821 while the ancestor of genotype GII emerged in 1879. After the 1950s, there was rapid expansion in the spread of FCV which extended from eastern parts to regions in southwest, southeast, and northeast after 1990. The analysis on recombinant evolution suggests that FCV can undergo recombination within same genotypes or across different genotypes enhancing its cross-species transmission and infectivity capabilities. Amino acid sequence analysis reveals mutations at key amino acid site position 481 involved in receptor binding where K mutated into E or N in domestic prevalent strains recently. All seven amino acid sites related virulence have undergone mutations. The results of protein adaptability analysis indicate that the amino acid residue at position 281 (N) in the VP1 protein is a site of adaptive selection. In some strains, the amino acid at this position has mutated from N to G, S, or R. Further molecular dynamics simulations reveal that these mutations affect the structural stability of the VP1 protein. The results of this study are essential for gaining a thorough understanding of the FCV profile in China and can be used to create better prevention and control strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.